A novel small molecule remyelination therapy for multiple sclerosis.

Yang Y, Bai B, Knutsen LJS, Hamlyn RJ, Cui QL, Antel J, Macklin W, Medicetty S, Trapp BD

Open source

DOI
10.1038/s44386-026-00060-7
Published
2026 Jul 23
Container
npj drug discovery
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s44386-026-00060-7,
  title = {A novel small molecule remyelination therapy for multiple sclerosis.},
  author = {Yang Y and Bai B and Knutsen LJS and Hamlyn RJ and Cui QL and Antel J and Macklin W and Medicetty S and Trapp BD},
  year = {2026},
  journal = {npj drug discovery},
  doi = {10.1038/s44386-026-00060-7},
  url = {https://doi.org/10.1038/s44386-026-00060-7}
}

RIS

TY  - JOUR
TI  - A novel small molecule remyelination therapy for multiple sclerosis.
AU  - Yang Y
AU  - Bai B
AU  - Knutsen LJS
AU  - Hamlyn RJ
AU  - Cui QL
AU  - Antel J
AU  - Macklin W
AU  - Medicetty S
AU  - Trapp BD
PY  - 2026
JO  - npj drug discovery
DO  - 10.1038/s44386-026-00060-7
UR  - https://doi.org/10.1038/s44386-026-00060-7
ER  - 

APA

Y, Y., B, B., LJS, K., RJ, H., QL, C., J, A., W, M., S, M., & BD, T. (2026). A novel small molecule remyelination therapy for multiple sclerosis.. npj drug discovery. https://doi.org/10.1038/s44386-026-00060-7

Source records